Format

Send to

Choose Destination
Intensive Care Med. 2007 Jul;33(7):1199-1203. doi: 10.1007/s00134-007-0649-4. Epub 2007 Apr 28.

Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndrome.

Author information

1
Institut für Pharmakogenetik, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany. Michael.adamzik@uni-duisburg-essen.de.
2
Klinik für Anästhesiologie und Intensivmedizin, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany. Michael.adamzik@uni-duisburg-essen.de.
3
Institut für Pharmakogenetik, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.
4
Klinik für Anästhesiologie und Intensivmedizin, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Abstract

OBJECTIVE:

This study investigated whether the insertion/deletion polymorphism in the promoter of NFKB1 is associated with severity and/or mortality in ARDS.

DESIGN AND SETTING:

Prospective study in a mixed anesthesiological ICU of the University Hospital Essen.

PATIENTS AND PARTICIPANTS:

103 adult patients with ARDS (white Germans).

MEASUREMENTS AND RESULTS:

Patients with ARDS were genotyped for the insertion/deletion polymorphism in the promoter of NFKB1 (-94ins/delATTG). In ARDS patients genotypes differed significantly between those with severe ARDS [Lung Injury Score (LIS)>or=3; 23 homozygote deletion (DD), heterozygote (ID) 31, and homozygote insertion wildtype (II) 23], and those with LIS below 3 (1 DD, 9 ID, 16 II). Likewise, the frequency of the D allele was significantly less in patients with higher LIS (50% D) than lower LIS (21% D). Using these values produces a significantly higher OR of 16.0 (95% CI 1.96-130.9) for DD than for II, while the OR for ID vs. II was 2.4 (95% CI 0.9-6.4). Genotypes of the NFKB1 promoter polymorphism were associated neither with 30-day survival nor with duration of ICU stay.

CONCLUSIONS:

The insertion/deletion polymorphism in the promoter of NFKB1 influences the severity but not the mortality of ARDS.

PMID:
17468848
DOI:
10.1007/s00134-007-0649-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center